168 related articles for article (PubMed ID: 4999485)
1. The effects of MP virus infection in lymphoma.
Horton J; Hotchin JE; Olson KB; Davies JN
Cancer Res; 1971 Aug; 31(8):1066-8. PubMed ID: 4999485
[No Abstract] [Full Text] [Related]
2. Immunologic studies in lymphoma and leukemia, and exploration of antitumor immunotherapy.
Sokal JE
J Surg Oncol; 1973 Jun; 5(6):557-66. PubMed ID: 4589652
[No Abstract] [Full Text] [Related]
3. [Treatment of lymphatic system neoplasms at the Regional Oncological Hospital in Lublin].
Zurawska-Poleszak S; Peszyński J
Pol Tyg Lek; 1973 Jan; 28(5):177-9. PubMed ID: 4569949
[No Abstract] [Full Text] [Related]
4. Delay in progression of malignant lymphoma after BCG vaccination.
Sokal JE; Aungst CW; Snyderman M
N Engl J Med; 1974 Dec; 291(23):1226-30. PubMed ID: 4609380
[No Abstract] [Full Text] [Related]
5. Immune status in untreated patients with lymphoreticular malignancy--a multifactorial study.
Hancock BW; Bruce L; Sugden P; Ward AM; Richmond J
Clin Oncol; 1977 Mar; 3(1):57-63. PubMed ID: 324686
[No Abstract] [Full Text] [Related]
6. [Lymphomas and immunity].
Kouvalainen K
Duodecim; 1970; 86(16):886-94. PubMed ID: 4917099
[No Abstract] [Full Text] [Related]
7. [Ways of improving the results of malignant lymphoma treatment].
Iakhontov NE; Pugachev VF; Terent'eva NA; Kuranov LA
Vestn Akad Med Nauk SSSR; 1980; (5):32-8. PubMed ID: 6994392
[No Abstract] [Full Text] [Related]
8. [Management of malignant lymphomas].
Holsti LR
Duodecim; 1976; 92(24):1370-83. PubMed ID: 795630
[No Abstract] [Full Text] [Related]
9. Cellular immune responses and prognosis in malignant lymphomas.
Sokal JE; Aungst CW
Natl Cancer Inst Monogr; 1971 Dec; 34():109-12. PubMed ID: 4946576
[No Abstract] [Full Text] [Related]
10. [Association of intralymphatic radiotherapy and alkylating agents in the treatment of retroperitoneal hematosarcomas].
Bonadonna G; Chiappa S; Di Pietro S; Marano O; Molinari R; Uslenghi C
Nouv Rev Fr Hematol; 1967; 7(3):381-92. PubMed ID: 4229322
[No Abstract] [Full Text] [Related]
11. [Therapy of non-Hodgkin's lymphomas].
Jancić MC; Vulevic I
Srp Arh Celok Lek; 1981; 109(5-6):665-76. PubMed ID: 7048567
[No Abstract] [Full Text] [Related]
12. [Study of immunoglobulin in malignant lymphoma].
Isobe T; Kato T
Saishin Igaku; 1968 Nov; 23(11):2454-9. PubMed ID: 4180058
[No Abstract] [Full Text] [Related]
13. [Treatment of cancer patients with a compression mediastinal syndrome].
Zmeul VK
Vopr Onkol; 1971; 17(11):90-2. PubMed ID: 4945609
[No Abstract] [Full Text] [Related]
14. [Acquisitions and problems in the cellular and serum immunology of malignant blood diseases].
CAJANO A; FAIELLA A
Riv Emoter Immunoematol; 1960; 7():317-34. PubMed ID: 13689856
[No Abstract] [Full Text] [Related]
15. [Quantitative immunoglobulin determination in paraproteinemias, lymphogranulomatosis and lympho-reticulosarcomatosis].
Patakfalvi A; Simon K; Horváth T; Böhm G
Orv Hetil; 1971 Jan; 112(2):75-8. PubMed ID: 4924220
[No Abstract] [Full Text] [Related]
16. Early splenectomy in lymphoproliferative disorders.
Yam LT; Crosby WH
Arch Intern Med; 1974 Feb; 133(2):270-4. PubMed ID: 4591267
[No Abstract] [Full Text] [Related]
17. [Immunodeficiency and lymphomas].
Leoni P; Montroni M; Montillo M; Centurioni R; Salvi A; Fanciulli E
G Clin Med; 1981 Sep; 62(9):648-55. PubMed ID: 7033028
[No Abstract] [Full Text] [Related]
18. [Treatment of malignant lymphoma].
Stojimirović E; Jokanović R; Vuković I; Kojić V; Bubnjevacki G
Srp Arh Celok Lek; 1973 May; 101(5):329-37. PubMed ID: 4595466
[No Abstract] [Full Text] [Related]
19. [IgM monoclonal gammapathies: a spectrum of hematologic-clinical options (analysis of 24 cases)].
Sánchez Fayos J; Outeiriño J; Ortíz Masllorens F; Pérez Piño T; de Villalobos E; Calleja JL; Paniagua G
Rev Clin Esp; 1975 Sep; 138(6):507-13. PubMed ID: 1105700
[No Abstract] [Full Text] [Related]
20. Passive transfer of tuberculin sensitivity to patients with Hodgkin's disease.
Müftüoğlu AU; Balkuv S
N Engl J Med; 1967 Jul; 277(3):126-9. PubMed ID: 4861560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
